John C. Arthur
Corporate Officer/Principal en HERON THERAPEUTICS, INC. .
Perfil
John C.
Arthur is currently the Vice President-Manufacturing & Supply at Heron Therapeutics, Inc. He was previously the Senior Director-Manufacturing at Auspex Pharmaceuticals, Inc. and the Vice President-Manufacturing & CMC at Mast Therapeutics, Inc. Dr. Arthur holds a doctorate degree from the University of South Carolina and an undergraduate degree from Western Washington University.
Cargos activos de John C. Arthur
| Empresas | Cargo | Inicio |
|---|---|---|
| HERON THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2017 |
Antiguos cargos conocidos de John C. Arthur.
| Empresas | Cargo | Fin |
|---|---|---|
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2016 |
| AUSPEX PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2013 |
Formación de John C. Arthur.
| University of South Carolina | Doctorate Degree |
| Western Washington University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- John C. Arthur
